Kolmar BioTech, Inc. (KOSDAQ:215380)

Kolmar BioTech Revenue

Kolmar BioTech had revenue of 11.03B KRW in the quarter ending March 31, 2026, with 32.69% growth. This brings the company's revenue in the last twelve months to 40.30B, down -2.54% year-over-year. In the year 2025, Kolmar BioTech had annual revenue of 37.59B, down -12.99%.

• Revenue (ttm): 40.30B
• Revenue Growth: -2.54%
• P/S Ratio: 0.90
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 36.35B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	37.59B	-5.61B	-12.99%
Dec 31, 2024	43.20B	4.58B	11.87%
Dec 31, 2023	38.62B	-8.30B	-17.70%
Dec 31, 2022	46.92B	15.68B	50.20%
Dec 31, 2021	31.24B	-6.11B	-16.35%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 2, 2026

Data Sources Report a data error